Easy approach to detect cell immunity to COVID vaccines in common variable immunodeficiency patients | Zendy

Yvelise Barrios | Zendy; Andrés Franco | Zendy; Cristina ÁlavaCruz | Zendy; Ricardo CuestaMartín de la Cámara | Zendy; Carmen Cámara | Zendy; Víctor Matheu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Easy approach to detect cell immunity to COVID vaccines in common variable immunodeficiency patients

Author(s) -

Yvelise Barrios,

Andrés Franco,

Cristina ÁlavaCruz,

Ricardo CuestaMartín de la Cámara,

Carmen Cámara,

Víctor Matheu

Publication year - 2022

Publication title -

allergologia et immunopathologia

Language(s) - English

Resource type - Journals

eISSN - 1578-1267

pISSN - 0301-0546

DOI - 10.15586/aei.v50i3.583

Subject(s) - common variable immunodeficiency , medicine , ex vivo , immunology , immune system , antibody , vaccination , in vivo , immunity , cellular immunity , immunodeficiency , immunopathology , biology , microbiology and biotechnology

Patients with primary antibody deficiencies, such as Common Variable Immunodeficiency (CVID), have some problems to assess immune response after coronavirus disease (COVID) vaccination. Cutaneous delayed-type hypersensitivity (DTH) has the potential to be used as a useful, simple, and cheaper tool to assess T-cell (T lymphocyte) function.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research